NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of the market Tuesday that its fourth quarter 2013 revenues grew 54 percent year over year and 23 percent sequentially.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm reported Q4 revenues of $9.1 million, compared to just $5.9 million in Q4 2012 and up from $7.4 million in Q3 2013. It matched the consensus Wall Street estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.